Ausgabe 3/2017
Inhalt (25 Artikel)
The role of bevacizumab in the treatment of glioblastoma
Roberto Jose Diaz, Sheikh Ali, Mehreen Gull Qadir, Macarena I. De La Fuente, Michael E. Ivan, Ricardo J. Komotar
Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations
S. Balendran, S. Liebmann-Reindl, A. S. Berghoff, T. Reischer, N. Popitsch, C. B. Geier, L. Kenner, P. Birner, B. Streubel, M. Preusser
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor
Yunxiang Chen, Rui Li, Minhong Pan, Zhumei Shi, Wei Yan, Ning Liu, Yongping You, Junxia Zhang, Xiefeng Wang
Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases
Prit Benny Malgulwar, Aruna Nambirajan, Pankaj Pathak, Mohammed Faruq, Vaishali Suri, Chitra Sarkar, Amandeep Jagdevan, Bhawani Shankar Sharma, Mehar Chand Sharma
Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence
Andrea O. Fontana, Deborah Piffaretti, Francesco Marchi, Floriana Burgio, Ana Bela Faia-Torres, Paolo Paganetti, Sandra Pinton, Uwe Pieles, Michael Reinert
Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members
Baoxin Zhang, Chenfu Shen, Fengyun Ge, Tingting Ma, Zuping Zhang
Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity
Erika Rodrigues-Silva, Edilene S. Siqueira-Santos, Juliana S. Ruas, Raffaela S. Ignarro, Tiago R. Figueira, Fábio Rogério, Roger F. Castilho
Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review
Timothy L. Sita, Katarina G. Petras, Q. Eileen Wafford, Mark A. Berendsen, Tim J. Kruser
Analysis of surgical and MRI factors associated with cerebellar mutism
Anjali Sergeant, Michelle Masayo Kameda-Smith, Branavan Manoranjan, Brij Karmur, JoAnn Duckworth, Tina Petrelli, Katey Savage, Olufemi Ajani, Blake Yarascavitch, M. Constantine Samaan, Katrin Scheinemann, Cheryl Alyman, Saleh Almenawer, Forough Farrokhyar, Adam J. Fleming, Sheila Kumari Singh, Nina Stein
MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma
Jun Zhang, Jianguang Lv, Feng Zhang, Hongmin Che, Qiwei Liao, Wobin Huang, Shaopeng Li, Yuqian Li
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series
Marc C. Chamberlain, Bryan T. Kim
Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab
Timo A. Auer, Mirjam Renovanz, Federico Marini, Marc A. Brockmann, Yasemin Tanyildizi
Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC)
E. Story, D. L. Johnston, U. Bartels, A. S. Carret, B. Crooks, D. D. Eisenstat, C. Fryer, L. Lafay-Cousin, V. Larouche, B. Wilson, S. Zelcer, M. Silva, J. Brossard, E. Bouffet, D. L. Keene
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
Priya Kumthekar, Sean Grimm, James Chandler, Minesh Mehta, Maryanne Marymont, Robert Levy, Kenji Muro, Irene Helenowski, Katie McCarthy, Leanne Fountas, Jeffrey Raizer
Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma
Penny Fang, Wen Jiang, Pamela Allen, Isabella Glitza, Nandita Guha, Patrick Hwu, Amol Ghia, Jack Phan, Anita Mahajan, Hussein Tawbi, Jing Li
Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations
Charles Vecht, Alberto Duran-Peña, Caroline Houillier, Thomas Durand, Laurent Capelle, Gilles Huberfeld
Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
Susan Byrne, Steve Connor, Karine Lascelles, Ata Siddiqui, Darren Hargrave, Rosalie E. Ferner
MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma
Byung Sup Kim, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma
Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas
Matthieu Peyre, Loïc Feuvret, Marc Sanson, Soledad Navarro, Anne-Laure Boch, Hugues Loiseau, Michel Kalamarides
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
Kira Marie Voß, Dorothee Cäcilia Spille, Cristina Sauerland, Eric Suero Molina, Caroline Brokinkel, Werner Paulus, Walter Stummer, Markus Holling, Astrid Jeibmann, Benjamin Brokinkel
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting
Mirjam Renovanz, Marlene Hechtner, Mareile Janko, Karoline Kohlmann, Jan Coburger, Minou Nadji-Ohl, Jochem König, Florian Ringel, Susanne Singer, Anne-Katrin Hickmann
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient
Isabella C. Glitza, Sherise D. Ferguson, Nandita Guha-Thakurta
MGMT promoter methylation status: time for a frank discussion
Niamh Coleman, Leslie Bridges, Frank Saran